These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37786978)

  • 1. Characterizing the cutaneous late effects of allogeneic hematopoietic stem cell transplantation: A systematic review.
    Bourkas AN; Sibbald C; Chan AW; Schechter T; Ali M; Pullattayil AK; Levy R
    Pediatr Transplant; 2024 Feb; 28(1):e14618. PubMed ID: 37786978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin Cancer Risk in Hematopoietic Stem-Cell Transplant Recipients Compared With Background Population and Renal Transplant Recipients: A Population-Based Cohort Study.
    Omland SH; Gniadecki R; Hædersdal M; Helweg-Larsen J; Omland LH
    JAMA Dermatol; 2016 Feb; 152(2):177-83. PubMed ID: 26454261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary skin neoplasms in patients after autologous and allogeneic hematopoietic stem cell transplantation procedures.
    Szlauer-Stefańska A; Kamińska-Winciorek G; Giebel S; Bagłaj M
    Adv Clin Exp Med; 2020 Oct; 29(10):1221-1230. PubMed ID: 33064381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk Factors for Keratinocyte Carcinoma in Recipients of Allogeneic Hematopoietic Cell Transplants.
    Scott JF; Brough KR; Grigoryan KV; Muzic JG; Kim GY; Conic RRZ; Hill ST; Brewer JD; Baum CL; Litzow MR; Hogan WJ; Patnaik MS; Hashmi SK; Lazarus HM; Bordeaux JS; Thompson CL; Gerstenblith MR; Lehman JS
    JAMA Dermatol; 2020 Jun; 156(6):631-639. PubMed ID: 32267479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous Malignant Neoplasms in Hematopoietic Cell Transplant Recipients: A Systematic Review.
    DePry JL; Vyas R; Lazarus HM; Caimi PF; Gerstenblith MR; Bordeaux JS
    JAMA Dermatol; 2015 Jul; 151(7):775-82. PubMed ID: 25902409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic hematopoietic stem cell transplant recipients and parasitic diseases: A review of the literature of clinical cases and perspectives to screen and follow-up active and latent chronic infections.
    Fabiani S; Fortunato S; Petrini M; Bruschi F
    Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28128496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of skin cancers in pediatric solid organ transplant patients: A systematic review.
    Sachdeva M; Lara-Corrales I; Pope E; Chan AW; Parekh RS; Kitchlu A; Sibbald C
    Pediatr Transplant; 2022 Feb; 26(1):e14146. PubMed ID: 34562053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonmalignant late cutaneous changes after allogeneic hematopoietic stem cell transplant in children.
    Huang JT; Song JS; Hawryluk EB; London WB; Guo D; Sridharan M; Fisher DE; Lehmann LE; Duncan CN
    J Am Acad Dermatol; 2018 Aug; 79(2):230-237. PubMed ID: 29588248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin cancer risk after hematopoietic stem cell transplantation: a systematic review and meta-analysis.
    Mansilla-Polo M; López-Davia J; De Unamuno-Bustos B; Martín-Torregrosa D; Abril-Pérez C; Ezzatvar Y; Botella-Estrada R
    Int J Dermatol; 2024 Jul; ():. PubMed ID: 38987869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The incidence of autoimmune hemolytic anemia in pediatric hematopoietic stem cell recipients post-first and post-second hematopoietic stem cell transplant.
    Ahmed I; Teruya J; Murray-Krezan C; Krance R
    Pediatr Transplant; 2015 Jun; 19(4):391-8. PubMed ID: 25809012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent occurrence of cytomegalovirus retinitis during immune reconstitution warrants regular ophthalmic screening in high-risk pediatric allogeneic hematopoietic stem cell transplant recipients.
    Hiwarkar P; Gajdosova E; Qasim W; Worth A; Breuer J; Chiesa R; Ridout D; Edelsten C; Moore A; Amrolia P; Veys P; Rao K
    Clin Infect Dis; 2014 Jun; 58(12):1700-6. PubMed ID: 24700657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial infections in pediatric hematopoietic stem cell transplantation recipients: incidence, epidemiology, and spectrum of pathogens: report of the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation.
    Zając-Spychała O; Wachowiak J; Pieczonka A; Siewiera K; Frączkiewicz J; Kałwak K; Gorczyńska E; Chybicka A; Czyżewski K; Jachna-Sawicka K; Wysocki M; Klepacka J; Goździk J; Zaucha-Prażmo A; Kowalczyk JR; Styczyński J
    Transpl Infect Dis; 2016 Oct; 18(5):690-698. PubMed ID: 27479544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High incidence of oral squamous cell carcinoma independent of HPV infection after allogeneic hematopoietic SCT in Taiwan.
    Chen MH; Chang PM; Li WY; Hsiao LT; Hong YC; Liu CY; Gau JP; Liu JH; Chen PM; Chiou TJ; Tzeng CH
    Bone Marrow Transplant; 2011 Apr; 46(4):567-72. PubMed ID: 20622906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First-line allogeneic hematopoietic stem cell transplantation of HLA-matched sibling donors compared with first-line ciclosporin and/or antithymocyte or antilymphocyte globulin for acquired severe aplastic anemia.
    Peinemann F; Bartel C; Grouven U
    Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD006407. PubMed ID: 23881658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of graft-versus-host disease in the development of secondary skin cancers in hematopoietic stem cell transplant recipients: A meta-analysis.
    Rambhia PH; Conic RZ; Atanaskova-Mesinkovska N; Piliang M; Bergfeld WF
    J Am Acad Dermatol; 2018 Aug; 79(2):378-380.e3. PubMed ID: 29339241
    [No Abstract]   [Full Text] [Related]  

  • 16. Gut Immunomodulation with Vedolizumab prior to Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients with Inflammatory Bowel Disease.
    Chopra Y; Acevedo K; Muise A; Frost K; Schechter T; Krueger J; Ali M; Chiang KY; Kim VH; Grunebaum E; Wall D
    Transplant Cell Ther; 2024 May; 30(5):546.e1-546.e7. PubMed ID: 38458476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes with CD34-Selected Stem Cell Boost for Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.
    Shahzad M; Siddiqui RS; Anwar I; Chaudhary SG; Ali T; Naseem M; Ahmed TF; Ahmed Z; Khurana S; Ahmed N; Balusu R; Singh AK; Hematti P; Callander NS; Abhyankar SH; McGuirk JP; Mushtaq MU
    Transplant Cell Ther; 2021 Oct; 27(10):877.e1-877.e8. PubMed ID: 34284148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuing increased risk of oral/esophageal cancer after allogeneic hematopoietic stem cell transplantation in adults in association with chronic graft-versus-host disease.
    Atsuta Y; Suzuki R; Yamashita T; Fukuda T; Miyamura K; Taniguchi S; Iida H; Uchida T; Ikegame K; Takahashi S; Kato K; Kawa K; Nagamura-Inoue T; Morishima Y; Sakamaki H; Kodera Y;
    Ann Oncol; 2014 Feb; 25(2):435-41. PubMed ID: 24399081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic monitoring of cytomegalovirus (CMV) enzyme-linked immune absorbent spot (ELISPOT) for controlling clinically significant CMV infection in pediatric allogeneic hematopoietic stem cell transplant recipients.
    Seo E; Choi ES; Kim JH; Kim H; Koh KN; Im HJ; Lee J
    PLoS One; 2021; 16(2):e0246191. PubMed ID: 33544726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Characteristics and Outcomes of COVID-19 in Pediatric and Early Adolescent and Young Adult Hematopoietic Stem Cell Transplant Recipients: A Cohort Study.
    Bhatt NS; Sharma A; St Martin A; Abid MB; Brown VI; Diaz Perez MA; Frangoul H; Gadalla SM; Herr MM; Krem MM; Lazarus HM; Martens MJ; Mehta PA; Nishihori T; Prestidge T; Pulsipher MA; Rangarajan HG; Williams KM; Winestone LE; Yin DE; Riches ML; Dandoy CE; Auletta JJ
    Transplant Cell Ther; 2022 Oct; 28(10):696.e1-696.e7. PubMed ID: 35798233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.